CBOE · US Equities - Factor & Thematic · USA
The companies inside ARKW trade 107% above what we estimate they are worth. We could give a verdict on 81% of the fund's weight: 44 holdings as reported to the SEC at 31 Jul 2026.
Where the money is: 3% in companies in the buy zone, 4% about fairly valued, 74% overvalued, 19% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 0.76% a year: on $10,000 held flat that is $760 over 10 years and $1,520 over 20.